Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A sustainable future for peritoneal dialysis: a patient survey on green nephrology.

Journal of nephrology·2026
Same author

Correction: Home-based Rehabilitation With A Novel Digital Biofeedback System versus Conventional In-person Rehabilitation after Total Knee Replacement: a feasibility study.

Scientific reports·2026
Same author

Proteinuria remission profiles in obesity-related kidney disease after bariatric surgery.

American journal of physiology. Renal physiology·2026
Same author

Two Faces of Leadership: Transformational and Abusive Pathways to Job Satisfaction, Affective Organizational Commitment, and Turnover Intentions.

Psychological reports·2026
Same author

Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.

Blood advances·2026
Same author

Untargeted Urinary Proteomics Uncovers Nephroprotective and Systemic Adaptations after Obesity Surgery-Induced Weight Loss.

Journal of proteome research·2025

Related Experiment Video

Updated: May 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Modelling competing risks in nephrology research: an example in peritoneal dialysis.

Laetitia Teixeira, Anabela Rodrigues, Maria J Carvalho

    BMC Nephrology
    |May 28, 2013
    PubMed
    Summary

    Standard survival analysis overestimates peritonitis risk in peritoneal dialysis patients. Competing risk analysis provides accurate estimates, identifying age and gender as key factors for peritonitis.

    More Related Videos

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
    06:27

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

    Published on: July 20, 2022

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    Related Experiment Videos

    Last Updated: May 11, 2026

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
    06:27

    A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

    Published on: July 20, 2022

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
    07:11

    Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

    Published on: July 19, 2018

    Area of Science:

    • Nephrology
    • Biostatistics
    • Epidemiology

    Background:

    • Accurate modeling of competing risks is crucial in nephrology research, particularly for peritoneal dialysis (PD) studies.
    • Standard survival analysis methods, such as the Kaplan-Meier method, can produce biased estimates when competing risks are present.
    • Competing risk analysis offers a more appropriate statistical approach for these scenarios.

    Purpose of the Study:

    • To quantify the bias introduced by standard survival analysis in estimating peritonitis-free survival in PD patients.
    • To present and evaluate alternative statistical methods that account for competing risks.
    • To identify patient characteristics associated with peritonitis risk in the presence of competing events.

    Main Methods:

    • Analysis of data from 449 patients in a university hospital's PD program (October 1985 - June 2011).
    • Application of cumulative incidence function and competing risk regression models, including cause-specific and subdistribution hazards.
    • Comparison of results from standard survival analysis with competing risk models.

    Main Results:

    • The Kaplan-Meier method significantly overestimated the probability of first peritonitis.
    • The cause-specific hazard model identified older age (≥55 years) and prior hemodialysis as predictors of shorter time to first peritonitis.
    • The subdistribution hazard model, accounting for competing risks, found age and female gender to be associated with a higher probability of first peritonitis.

    Conclusions:

    • Kaplan-Meier estimates are biased in the presence of competing risks, overestimating event probabilities.
    • Competing risk analysis methods yield unbiased cumulative incidence estimates for specific outcomes.
    • Multivariable regression models, utilizing cause-specific or subdistribution hazards, are recommended for analyzing competing risks in PD research.